DARTMOUTH, NS, May 2 /CNW/ - The American Heart Association (AHA)
recently issued its first ever statement on triglyceride management
that includes recommendations for Omega-3 EPA/DHA intake. Elevated
triglyceride levels have long been associated with cardiovascular
disease (CVD). According to the AHA more than 31% of the United States
population has borderline high triglyceride levels. Furthermore, AHA's
2006 statistical data estimates that 81,100,000 people in the United
States have one or more forms of cardiovascular disease, claiming
831,272 lives in that same year.
In conjunction with other important lifestyle changes, the AHA
recommends 0.5 - 1g of Omega-3 EPA and DHA for individuals with
borderline fasting triglyceride levels (150-199mg/dL), 1 - 2g for
individuals with high fasting triglyceride levels (200-499mg/dL), and 2
- 4g for individuals with very high fasting triglyceride levels
(≥500mg/dL). The AHA has also previously recommended that normal
healthy individuals consume a variety of fish (preferably oily), and a
daily intake of 1g of Omega-3 EPA and DHA for patients with documented
coronary heart disease.
The recent statement issued by AHA is a very positive step for improving
consumers' understanding of the role of triglycerides in CVD
management. Although awareness of the health benefits of Omega-3 is
very high among consumers, many still do not understand the different
forms of Omega-3 (EPA, DHA and ALA), or the health benefits of each.
It is important for consumers to understand that fish provides both EPA
and DHA, whereas most algae sources provide only DHA. Furthermore,
while ALA is an essential fatty acid, many of the reported health
benefits associated with Omega-3 have been the result of
supplementation with EPA and DHA. While the body can theoretically
convert ALA into EPA and DHA, the actual conversion rate is very low.
In fact, many studies suggest that the conversion rate can be as low as
1% or less. As such, fish, fish oil supplements, and food products
fortified with fish oil are the best sources of Omega-3 for consumers.
About Ocean Nutrition Canada Limited (ONC):
Ocean Nutrition Canada Limited (ONC) is a privately held company, whose
major shareholder is Clearwater Fine Foods Incorporated. Clearwater
Fine Foods Incorporated is a diversified holding/investment company
whose significant holdings include a controlling interest in Clearwater
Seafood's Limited Partnership, the world's largest integrated shellfish
harvester and processor.
ONC is the world's largest supplier of Omega-3 EPA/DHA ingredients from
fish oil, marketed into the dietary supplement and food manufacturing
markets. To date, MEG-3® ingredients have been included in over 96 billion servings of food and
supplement products worldwide. For more information about ONC, please
visit www.ocean-nutrition.com, and for information on the health benefits of Omega-3 EPA/DHA please
Omega-3 is a family of essential fatty acids (EFA), including EPA
(eicosapentaenoic acid), DHA (docosahexaenoic acid), and ALA
(alpha-linolenic acid). Oily fish (such as sardines, anchovies,
mackerel, and salmon) are the major known natural sources of Omega-3
EPA/DHA. ALA is found in plants, such as flax and chia. It is
important to note that EPA and DHA are the primary contributors of the
many health benefits associated with Omega-3. While the body can
convert ALA into EPA/DHA, it does so very inefficiently (typically less
than 1%), making it difficult to derive Omega-3-related health benefits
from plant-sourced ALA. Furthermore, although Omega-3 EPA/DHA is
important to overall good health, the human body is not able to produce
sufficient quantities on its own, so supplementation is required,
either by eating oily fish or foods fortified with Omega-3 EPA/DHA, or
by taking fish oil supplements. Learn more about the health benefits
of Omega-3 EPA/DHA at www.meg-3.com.
SOURCE OCEAN NUTRITION CANADA LTD.
For further information:
Ocean Nutrition Canada Ltd.